Elanco FY26 Q2 adjusted EPS rises 31% to $0.34; revenue increases 10% to $1.37 billion

Reuters2026/08/05 10:27

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Elanco Animal Health posted Q2 GAAP net income of USD 54 million, up from USD 11 million; GAAP EPS rose to USD 0.11 from USD 0.02.
Revenue climbed 10% from a year earlier to USD 1.37 billion, driven by Pet Health sales of USD 718 million, up 12%.
Adjusted EBITDA increased 21% to USD 288 million; adjusted EBITDA margin widened 2 percentage points to 21.2%.
Zenrelia became the largest contributor to global growth, followed by Credelio Quattro; Befrena shipped to nearly 1,400 U.S. clinics.
Full-year guidance rose to revenue of USD 5.09 billion-USD 5.14 billion, adjusted EBITDA of USD 1.01 billion-USD 1.04 billion, adjusted EPS of USD 1.10-USD 1.16.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608050627PR_NEWS_USPR_____DE19523) on August 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Elanco FY26 Q2 adjusted EPS rises 31% to $0.34; revenue increases 10% to $1.37 billion

You may also like

Crypto prices